E74.03 Cori disease

Name of the Condition

• Cori disease (ICD-10 Code E74.03)

Summary

Cori disease is a glycogen storage disorder caused by a deficiency of the enzyme amylo-1,6-glucosidase (debranching enzyme). This deficiency impairs glycogen breakdown, leading to abnormal glycogen accumulation in the liver and muscles. The condition disrupts glucose homeostasis, resulting in hypoglycemia and other metabolic complications.

Causes

Cori disease is caused by genetic mutations in the AGL gene, which encodes the debranching enzyme. These mutations are inherited in an autosomal recessive pattern, meaning both parents must carry a mutated gene for a child to be affected. The enzyme deficiency prevents proper glycogen breakdown, disrupting energy storage and utilization.

Risk Factors

• Genetic predisposition or family history of Cori disease.
• Consanguinity (closely related parents), increasing the likelihood of inheriting recessive mutations.
• Ethnic or population-specific prevalence for certain genetic variants.

Symptoms

Symptoms typically appear in infancy or early childhood and may include:

• Hypoglycemia (low blood sugar), especially during fasting or illness.
• Enlarged liver (hepatomegaly) due to glycogen accumulation.
• Growth delays or failure to thrive.
• Muscle weakness or exercise intolerance.
• Elevated liver enzymes (transaminases).

Diagnosis

Diagnosis involves clinical evaluation, family history, and laboratory tests. Blood tests may show abnormal glucose or liver function. A muscle or liver biopsy can confirm glycogen accumulation. Genetic testing for AGL gene mutations is definitive.

Treatment Options

Treatment focuses on managing hypoglycemia and preventing complications. Options include:

• Frequent carbohydrate-rich meals or continuous feeding to maintain blood glucose.
• Uncooked cornstarch to provide sustained glucose release.
• Monitoring for liver or muscle involvement.
• Addressing growth delays with nutritional support.

Prognosis and Follow-Up

Prognosis varies; early diagnosis and management improve outcomes. Regular follow-up with a metabolic specialist is essential to monitor growth, liver function, and metabolic status. Lifelong dietary management is typically required.

Complications

• Severe hypoglycemia leading to seizures or coma.
• Progressive liver disease, including fibrosis or cirrhosis.
• Muscle weakness or myopathy.
• Growth failure or developmental delays.

Lifestyle & Prevention

• Maintain a consistent, high-carbohydrate diet to prevent hypoglycemia.
• Avoid prolonged fasting; use nighttime feeds or cornstarch for infants.
• Engage in regular, moderate exercise to support muscle health.
• Monitor growth and development closely.

When to Seek Professional Help

Seek immediate care for:

• Persistent hypoglycemia symptoms (e.g., confusion, seizures).
• Unexplained fatigue or muscle pain.
• Jaundice or worsening liver function.
• Growth delays or failure to thrive.

Tips for Medical Coders

Document the clinical presentation, including hypoglycemia, hepatomegaly, or muscle involvement, to support the diagnosis. Specify if genetic testing confirms AGL mutations. Ensure documentation aligns with the specific glycogen storage disorder subtype to justify E74.03.